Home > Bristol-Myers Squibb Co. > Common-Size Statement of Financial Position, Liabilities and Stockholders' Equity

Bristol-Myers Squibb Co. (BMY) | Common-Size Statement of Financial Position, Liabilities and Stockholders' Equity

See also

ˇ Show More

You have visited 10 password protected pages for free. Others contain data covered by .

Bristol-Myers Squibb Co., Common-Size Consolidated Statement of Financial Position, Liabilities and Stockholders' Equity

	Dec 31, 2010	Dec 31, 2009	Dec 31, 2008	Dec 31, 2007	Dec 31, 2006
Short-term borrowings
Accounts payable
Employee compensation and benefits
Royalties
Accrued research and development
Restructuring, current
Pension and postretirement benefits
Accrued litigation
Other
Accrued expenses	%	%	%	%	%
Deferred income
Accrued rebates and returns
U.S. and foreign income taxes payable
Dividends payable
Liabilities related to assets held for sale
Current liabilities	%	%	%	%	%
Pension, postretirement and postemployment liabilities
Deferred income
U.S. and foreign income taxes payable
Other liabilities
Long-term debt
Non-current liabilities	%	%	%	%	%
Total liabilities	%	%	%	%	%
Preferred stock, $2 convertible series, par value $1 per share
Common stock, par value of $0.10 per share
Capital in excess of par value of stock
Accumulated other comprehensive loss
Retained earnings
Cost of treasury stock
Bristol-Myers Squibb Company shareholders’ equity	%	%	%	%	%
Noncontrolling interest
Total equity	%	%	%	%	%
Total liabilities and equity	%	%	%	%	%